Ayala Pharmaceuticals Inc (fka ADXS)

[fbg0316]

Dan was a disgrace, wasting all that money on ramping up staff prematurely for the sake of his own "empire building" and putting extensive sharehdoler resources into AXAL to "hold out" yet now the technology appears dated and could be shelved. Would make a good case study on how bad management and poor business strategy can destroy significant value on an underlying platform that is worth a lot more if executed properly.